CW July 2003
Volume 12Issue Number 7 July 2003 ISSN 10593802 Biochemotherapy in Metastatic Melanoma: A Safe Outpatient Regimen, and Vitiligo as a Success MarkerMore efficient tumor-reactive T-cells can be developed by expanding the engineered T-cells that recognize the CD19 antigen expressed in B-cell tumor in the presence of CD80 and interleukin-15.
Go to Previous Page Go to Next Page Source & Additional Reading M. Sadelain et al., Nature Medicine, March 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
